About Trilantic North America
Trilantic North America is a New York-headquartered private equity firm partnering with management teams to drive growth across the healthcare and business services sectors. Within healthcare, its identified focus is care delivery and tech-enabled services rather than software platforms or therapeutics. Trilantic does not market itself as an AI specialist, so AI-enabled physician tools or workflow technologies will be evaluated through the lens of how they enhance underlying service businesses, support operating leverage, or create defensible commercial moats.
The firm invests at the growth stage with check sizes of $25M and above, typical for a North America-focused middle-market PE shop. It pursues both control and structured minority transactions, often emphasizing alignment with founder-CEOs and incumbent management teams. Geographic activity centers on the United States and Canada, with portfolio companies ranging across multi-site service operators and tech-enabled platforms benefiting from secular tailwinds in healthcare consumption.
Founders should prepare materials that highlight unit economics, organic growth, and acquisition pipelines, since add-ons are often a key value-creation lever for Trilantic-backed platforms. Limited public information is available about specific healthcare partner coverage, so warm introductions through investment banks, portfolio executives, and sector advisors remain the most reliable path. Pitches should emphasize operational maturity and cash flow predictability rather than early-stage product narratives.
Founder reviews
Pitch / review this investor
Have you raised from Trilantic North America? Founders only — share your honest experience (anonymous OK, moderated before publishing).